A new review of the emerging variants of concern (VOCs) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has caused the coronavirus disease 2019 (COVID-19) pandemic, shows that there is a major need to constantly re-evaluate the utility of existing therapeutics and vaccines against the virus and to develop new ones.
The paper, published online in the journal Viruses, points to the need to exploit the power of genomic sequencing to identify crucial mutations in order to adapt preventive and therapeutic measures accordingly.
